IBDEI0Y7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16885,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,16886,0)
 ;;=V16.3^^92^943^6
 ;;^UTILITY(U,$J,358.3,16886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16886,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,16886,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,16886,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,16887,0)
 ;;=V16.41^^92^943^9
 ;;^UTILITY(U,$J,358.3,16887,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16887,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,16887,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,16887,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,16888,0)
 ;;=V16.42^^92^943^10
 ;;^UTILITY(U,$J,358.3,16888,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16888,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,16888,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,16888,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,16889,0)
 ;;=V16.43^^92^943^11
 ;;^UTILITY(U,$J,358.3,16889,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16889,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,16889,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,16889,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,16890,0)
 ;;=V19.5^^92^943^13
 ;;^UTILITY(U,$J,358.3,16890,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16890,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,16890,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,16890,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,16891,0)
 ;;=V19.2^^92^943^14
 ;;^UTILITY(U,$J,358.3,16891,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16891,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,16891,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,16891,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,16892,0)
 ;;=V17.3^^92^943^16
 ;;^UTILITY(U,$J,358.3,16892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16892,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,16892,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,16892,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,16893,0)
 ;;=V16.6^^92^943^17
 ;;^UTILITY(U,$J,358.3,16893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16893,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,16893,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,16893,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,16894,0)
 ;;=V18.61^^92^943^19
 ;;^UTILITY(U,$J,358.3,16894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16894,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,16894,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,16894,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,16895,0)
 ;;=V17.0^^92^943^20
 ;;^UTILITY(U,$J,358.3,16895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16895,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,16895,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,16895,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,16896,0)
 ;;=V19.4^^92^943^21
 ;;^UTILITY(U,$J,358.3,16896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16896,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,16896,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,16896,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,16897,0)
 ;;=V17.1^^92^943^22
 ;;^UTILITY(U,$J,358.3,16897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16897,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,16897,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,16897,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,16898,0)
 ;;=V16.8^^92^943^12
 ;;^UTILITY(U,$J,358.3,16898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16898,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,16898,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,16898,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,16899,0)
 ;;=V11.1^^92^943^24
